Clinical Trial: A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Phase 3, Multi-Site, Double-Blind, Randomized, Forced Titration, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Fixed Combination Torcetrapib (CP 529,414)/Atorvastatin Administ

Brief Summary:

The Torcetrapib project was terminated on December 2, 2006 due to safety findings.

To assess the safety and efficacy of the fixed combination torcetrapib/atorvastatin in subjects with Fredrickson Type IV Hypertriglyceridemia.

Detailed Summary: For additional information please call: 1-800-718-1021
Sponsor: Pfizer

Current Primary Outcome: Change in HDL-C and non-HDL-C levels

Original Primary Outcome: Same as current

Current Secondary Outcome: Changes in levels of other lipid and biomarkers.

Original Secondary Outcome: Same as current

Information By: Pfizer

Dates:
Date Received: August 22, 2005
Date Started: February 2005
Date Completion: November 2006
Last Updated: November 15, 2007
Last Verified: March 2007